| 摘要 |
FIELD: medicine. ^ SUBSTANCE: invention relates to medicine and pharmacology and can be used for normalisation of gastro-intestinal tract microbiocoenosis. Invention represents pharmaceutical preparation which contains biologically active additive Rekicen, raftilose R-95, pharmacopeia lactose, MCC, gelatin, aerosil, calcium stearate with definite ratio of components. ^ EFFECT: invention ensures creating medication which possesses higher therapeutic activity with respect to recovering intestine biocoenosis in people with large intestine pathology due to combined application of medications regulating both growth and number and activity of bifidus, lacto bacteria and colibaccilus. ^ 6 ex |
